CD103 Expression on Blastic Plasmacytoid Dendritic Cell Neoplasms in Peripheral Blood and Bone Marrow Samples

<p>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive neoplasm which is typically CD4+, CD56+, and CD123+. There is limited information regarding CD103 expression on blastic plasmacytoid dendritic cell neoplasms. We identified six cases of BPDCN and all six had at least part...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ron Lee (Author), Sally Ullery (Author), Ron Thomason (Author)
פורמט: ספר
יצא לאור: Archives of Hematology Case Reports and Reviews - Peertechz Publications, 2020-05-01.
נושאים:
גישה מקוונת:Connect to this object online.
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
תיאור
סיכום:<p>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive neoplasm which is typically CD4+, CD56+, and CD123+. There is limited information regarding CD103 expression on blastic plasmacytoid dendritic cell neoplasms. We identified six cases of BPDCN and all six had at least partial CD103 expression (31-92% positive) with the majority having significant expression of CD103. </p>
DOI:10.17352/ahcrr.000022